Skip to main content
Erschienen in: Cancer Causes & Control 5/2020

19.03.2020 | Original Paper

The association between type 2 diabetes mellitus and bladder cancer risk among postmenopausal women

verfasst von: Yueyao Li, Michael S. Hendryx, Pengcheng Xun, Ka He, Aladdin H. Shadyab, Kathy Pan, Lihong Qi, Juhua Luo

Erschienen in: Cancer Causes & Control | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Evidence on the association between diabetes and risk of bladder cancer has been controversial. In addition, findings on the associations between duration of diabetes, diabetes treatment, and risk of bladder cancer have been inconsistent.

Methods

A total of 148,208 participants in Women’s Health Initiative study were included. Information on diabetes status, diabetes duration, and treatment was collected both at baseline and during follow-up. Information on potential confounders including age, race/ethnicity, education, occupation, family history of cancer, smoking status, alcohol consumption, total physical activity, body mass index, and daily dietary intake were collected at baseline. Bladder cancer cases were collected and confirmed by a centralized review of pathology reports. Cox proportional hazard models with time-varying covariates were used to examine associations of diabetes status, duration of diabetes, and diabetes treatment with bladder cancer risk.

Results

During a median follow-up of 18.5 years, 865 bladder cancer cases were identified. There were no significant associations of diabetes, duration of diabetes, or diabetes treatment with risk of bladder cancer. Participants with prevalent diabetes did not have significantly higher risk of bladder cancer compared with those without diabetes.

Conclusion

Diabetes was not significantly associated with risk of bladder cancer among postmenopausal women.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat National Heart L, Blood Institute (1975–2014) SEER Cancer Statistics Review, 1975–2014. National Cancer Institute, Bethesda, MD. Accessed 28 Jun 2017 National Heart L, Blood Institute (1975–2014) SEER Cancer Statistics Review, 1975–2014. National Cancer Institute, Bethesda, MD. Accessed 28 Jun 2017
2.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7–30CrossRef Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7–30CrossRef
3.
Zurück zum Zitat Al-Zalabani AH, Stewart KF, Wesselius A, Schols AM, Zeegers MP (2016) Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur J Epidemiol 31(9):811–851CrossRef Al-Zalabani AH, Stewart KF, Wesselius A, Schols AM, Zeegers MP (2016) Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur J Epidemiol 31(9):811–851CrossRef
4.
Zurück zum Zitat Dietrich K, Demidenko E, Schned A, Zens MS, Heaney J, Karagas MR (2011) Parity, early menopause and the incidence of bladder cancer in women: a case–control study and meta-analysis. Eur J Cancer 47(4):592–599CrossRef Dietrich K, Demidenko E, Schned A, Zens MS, Heaney J, Karagas MR (2011) Parity, early menopause and the incidence of bladder cancer in women: a case–control study and meta-analysis. Eur J Cancer 47(4):592–599CrossRef
5.
Zurück zum Zitat Scosyrev E, Noyes K, Feng C, Messing E (2009) Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 115(1):68–74CrossRef Scosyrev E, Noyes K, Feng C, Messing E (2009) Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 115(1):68–74CrossRef
6.
Zurück zum Zitat Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011) Association between smoking and risk of bladder cancer among men and women. JAMA 306(7):737–745CrossRef Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011) Association between smoking and risk of bladder cancer among men and women. JAMA 306(7):737–745CrossRef
7.
Zurück zum Zitat Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F (2017) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71(1):96–108CrossRef Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F (2017) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71(1):96–108CrossRef
8.
Zurück zum Zitat Babjuk M (2017) Trends in bladder cancer incidence and mortality: success or disappointment? Eur Urol 71(1):109–110CrossRef Babjuk M (2017) Trends in bladder cancer incidence and mortality: success or disappointment? Eur Urol 71(1):109–110CrossRef
9.
Zurück zum Zitat Leung MY, Carlsson NP, Colditz GA, Chang SH (2017) The burden of obesity on diabetes in the United States: medical expenditure panel survey, 2008 to 2012. Value Health 20(1):77–84CrossRef Leung MY, Carlsson NP, Colditz GA, Chang SH (2017) The burden of obesity on diabetes in the United States: medical expenditure panel survey, 2008 to 2012. Value Health 20(1):77–84CrossRef
10.
Zurück zum Zitat Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JM (2009) New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 32(9):1620–1625CrossRef Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JM (2009) New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 32(9):1620–1625CrossRef
11.
Zurück zum Zitat Luo J, Chlebowski R, Liu S, McGlynn KA, Parekh N, White DL et al (2013) Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women. Cancer Causes Control 24(3):577–585CrossRef Luo J, Chlebowski R, Liu S, McGlynn KA, Parekh N, White DL et al (2013) Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women. Cancer Causes Control 24(3):577–585CrossRef
12.
Zurück zum Zitat Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6(2):103–111CrossRef Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6(2):103–111CrossRef
13.
Zurück zum Zitat Anderson KE, Anderson E, Mink PJ, Hong CP, Kushi LH, Sellers TA et al (2001) Diabetes and endometrial cancer in the Iowa women's health study. Cancer Epidemiol Biomark Prev 10(6):611–616 Anderson KE, Anderson E, Mink PJ, Hong CP, Kushi LH, Sellers TA et al (2001) Diabetes and endometrial cancer in the Iowa women's health study. Cancer Epidemiol Biomark Prev 10(6):611–616
14.
Zurück zum Zitat El-Serag HBHH, Javadi F (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 4(3):369–380CrossRef El-Serag HBHH, Javadi F (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 4(3):369–380CrossRef
15.
Zurück zum Zitat Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA et al (2010) Diabetes and cancer: a consensus report. Diabetes Care 33(7):1674–1685CrossRef Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA et al (2010) Diabetes and cancer: a consensus report. Diabetes Care 33(7):1674–1685CrossRef
16.
Zurück zum Zitat Vermeulen SH, Hanum N, Grotenhuis AJ, Castano-Vinyals G, van der Heijden AG, Aben KK et al (2015) Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study. Br J Cancer 112(3):594–600CrossRef Vermeulen SH, Hanum N, Grotenhuis AJ, Castano-Vinyals G, van der Heijden AG, Aben KK et al (2015) Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study. Br J Cancer 112(3):594–600CrossRef
17.
Zurück zum Zitat Michaud DS (2007) Chronic inflammation and bladder cancer. Urol Oncol 25(3):260–268CrossRef Michaud DS (2007) Chronic inflammation and bladder cancer. Urol Oncol 25(3):260–268CrossRef
18.
Zurück zum Zitat Zhao HGH, Spitz MR, Lerner SP, Zhang K, Wu X (2003) Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol. 169(2):714–717CrossRef Zhao HGH, Spitz MR, Lerner SP, Zhang K, Wu X (2003) Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol. 169(2):714–717CrossRef
19.
Zurück zum Zitat Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R (2009) Diabetes and cancer. Endocr Relat Cancer 16(4):1103–1123CrossRef Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R (2009) Diabetes and cancer. Endocr Relat Cancer 16(4):1103–1123CrossRef
20.
Zurück zum Zitat La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P (1994) A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70(5):950–953CrossRef La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P (1994) A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70(5):950–953CrossRef
21.
Zurück zum Zitat MacKenzie T, Zens MS, Ferrara A, Schned A, Karagas MR (2011) Diabetes and risk of bladder cancer: evidence from a case–control study in New England. Cancer 117(7):1552–1556CrossRef MacKenzie T, Zens MS, Ferrara A, Schned A, Karagas MR (2011) Diabetes and risk of bladder cancer: evidence from a case–control study in New England. Cancer 117(7):1552–1556CrossRef
22.
Zurück zum Zitat Ng Y, Husain I, Waterfall N (2003) Diabetes mellitus and bladder cancer: an epidemiological relationship? Pathol Oncol Res 9(1):30–31CrossRef Ng Y, Husain I, Waterfall N (2003) Diabetes mellitus and bladder cancer: an epidemiological relationship? Pathol Oncol Res 9(1):30–31CrossRef
23.
Zurück zum Zitat Rousseau MC, Parent ME, Pollak MN, Siemiatycki J (2006) Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer 118(8):2105–2109CrossRef Rousseau MC, Parent ME, Pollak MN, Siemiatycki J (2006) Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer 118(8):2105–2109CrossRef
24.
Zurück zum Zitat Swerdlow AJ, Laing SP, Qiao Z, Slater SD, Burden AC, Botha JL et al (2005) Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 92(11):2070–2075CrossRef Swerdlow AJ, Laing SP, Qiao Z, Slater SD, Burden AC, Botha JL et al (2005) Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 92(11):2070–2075CrossRef
25.
Zurück zum Zitat Tripathi A, Folsom AR, Anderson KE, Iowa Women's Health S (2002) Risk factors for urinary bladder carcinoma in postmenopausal women. Cancer 95(11):2316–2323CrossRef Tripathi A, Folsom AR, Anderson KE, Iowa Women's Health S (2002) Risk factors for urinary bladder carcinoma in postmenopausal women. Cancer 95(11):2316–2323CrossRef
26.
Zurück zum Zitat Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA (2011) Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 128(3):635–643CrossRef Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA (2011) Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 128(3):635–643CrossRef
27.
Zurück zum Zitat Prizment AE, Anderson KE, Yuan JM, Folsom AR (2013) Diabetes and risk of bladder cancer among postmenopausal women in the Iowa Women's Health Study. Cancer Causes Control 24(3):603–608CrossRef Prizment AE, Anderson KE, Yuan JM, Folsom AR (2013) Diabetes and risk of bladder cancer among postmenopausal women in the Iowa Women's Health Study. Cancer Causes Control 24(3):603–608CrossRef
28.
Zurück zum Zitat Tseng CH (2011) Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan. Diabetologia 54(8):2009–2015CrossRef Tseng CH (2011) Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan. Diabetologia 54(8):2009–2015CrossRef
29.
Zurück zum Zitat Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166(17):1871–1877CrossRef Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166(17):1871–1877CrossRef
30.
Zurück zum Zitat Newton CC, Gapstur SM, Campbell PT, Jacobs EJ (2013) Type 2 diabetes mellitus, insulin-use and risk of bladder cancer in a large cohort study. Int J Cancer 132(9):2186–2191CrossRef Newton CC, Gapstur SM, Campbell PT, Jacobs EJ (2013) Type 2 diabetes mellitus, insulin-use and risk of bladder cancer in a large cohort study. Int J Cancer 132(9):2186–2191CrossRef
31.
Zurück zum Zitat Zhu Z, Wang X, Shen Z, Lu Y, Zhong S, Xu C (2013) Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies. BMC Cancer 13:310CrossRef Zhu Z, Wang X, Shen Z, Lu Y, Zhong S, Xu C (2013) Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies. BMC Cancer 13:310CrossRef
32.
Zurück zum Zitat Bazelier MTDVF, Vestergaard P, Leufkens HG, De Bruin ML (2013) Use of thiazolidinediones and risk of bladder cancer: disease or drugs? Curr Drug Saf 8(5):364–370CrossRef Bazelier MTDVF, Vestergaard P, Leufkens HG, De Bruin ML (2013) Use of thiazolidinediones and risk of bladder cancer: disease or drugs? Curr Drug Saf 8(5):364–370CrossRef
33.
Zurück zum Zitat Stefanick ML, Cochrane BB, Hsia J, Barad DH, Liu JH, Johnson SR (2003) The women's health initiative postmenopausal hormone trials: overview and baseline characteristics of participants. Ann Epidemiol 13(9):S78–S86CrossRef Stefanick ML, Cochrane BB, Hsia J, Barad DH, Liu JH, Johnson SR (2003) The women's health initiative postmenopausal hormone trials: overview and baseline characteristics of participants. Ann Epidemiol 13(9):S78–S86CrossRef
34.
Zurück zum Zitat Hays J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen C et al (2003) The women's health initiative recruitment methods and results. Ann Epidemiol 13(9):S18–S77CrossRef Hays J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen C et al (2003) The women's health initiative recruitment methods and results. Ann Epidemiol 13(9):S18–S77CrossRef
35.
Zurück zum Zitat Jackson JM, Defor TA, Crain AL, Kerby T, Strayer L, Lewis CE et al (2013) Self-reported diabetes is a valid outcome in pragmatic clinical trials and observational studies. J Clin Epidemiol 66:3CrossRef Jackson JM, Defor TA, Crain AL, Kerby T, Strayer L, Lewis CE et al (2013) Self-reported diabetes is a valid outcome in pragmatic clinical trials and observational studies. J Clin Epidemiol 66:3CrossRef
36.
Zurück zum Zitat Margolis KL, Qi L, Brzyski R, Bonds DE, Howard BV, Kempainen S et al (2008) Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials 5(3):240–247CrossRef Margolis KL, Qi L, Brzyski R, Bonds DE, Howard BV, Kempainen S et al (2008) Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials 5(3):240–247CrossRef
37.
Zurück zum Zitat Belin RJ, Greenland P, Allison M, Martin L, Shikany JM, Larson J et al (2011) Diet quality and the risk of cardiovascular disease: the Women's Health Initiative (WHI). Am J Clin Nutr 94(1):49–57CrossRef Belin RJ, Greenland P, Allison M, Martin L, Shikany JM, Larson J et al (2011) Diet quality and the risk of cardiovascular disease: the Women's Health Initiative (WHI). Am J Clin Nutr 94(1):49–57CrossRef
38.
Zurück zum Zitat Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC, Hu FB (2009) Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation 119(8):1093–1100CrossRef Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC, Hu FB (2009) Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation 119(8):1093–1100CrossRef
39.
Zurück zum Zitat Ritenbaugh C, Patterson RE, Chlebowski RT, Caan B, Fels-Tinker L, Howard B et al (2003) The women's health initiative dietary modification trial: overview and baseline characteristics of participants. Ann Epidemiol 13(9):S87–S97CrossRef Ritenbaugh C, Patterson RE, Chlebowski RT, Caan B, Fels-Tinker L, Howard B et al (2003) The women's health initiative dietary modification trial: overview and baseline characteristics of participants. Ann Epidemiol 13(9):S87–S97CrossRef
40.
Zurück zum Zitat Ogunleye AA, Ogston SA, Morris AD, Evans JM (2009) A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 101(7):1199–1201CrossRef Ogunleye AA, Ogston SA, Morris AD, Evans JM (2009) A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 101(7):1199–1201CrossRef
41.
Zurück zum Zitat Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159(12):1160–1167CrossRef Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159(12):1160–1167CrossRef
42.
Zurück zum Zitat Colhoun HM, Group SE (2009) Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52(9):1755–1765CrossRef Colhoun HM, Group SE (2009) Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52(9):1755–1765CrossRef
Metadaten
Titel
The association between type 2 diabetes mellitus and bladder cancer risk among postmenopausal women
verfasst von
Yueyao Li
Michael S. Hendryx
Pengcheng Xun
Ka He
Aladdin H. Shadyab
Kathy Pan
Lihong Qi
Juhua Luo
Publikationsdatum
19.03.2020
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 5/2020
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-020-01294-0

Weitere Artikel der Ausgabe 5/2020

Cancer Causes & Control 5/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.